Zacks: Analysts Anticipate Esperion Therapeutics Inc (ESPR) to Announce -$1.36 Earnings Per Share

Zacks: Analysts Anticipate Esperion Therapeutics Inc (ESPR) to Announce -$1.36 Earnings Per Share


Wall Street analysts predict that Esperion Therapeutics Inc will announce earnings of per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Esperion Therapeutics' earnings.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога